Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbubble contrast agents are tiny, gas-filled spheres—typically stabilized by a shell of lipid, protein, or polymer—administered intravenously to enhance ultrasound imaging. When subjected to an ultrasound field, microbubbles resonate, strongly scattering and reflecting ultrasound signals (“backscatter enhancement”) due to nonlinear oscillations that depend on their size, shell properties, and acoustic conditions. This resonance effect makes microbubbles highly efficient as contrast agents for diagnostic ultrasound and as facilitators of novel therapies, such as transiently increasing biological barriers (e.g., blood–brain barrier) and improving local drug delivery through mechanisms like stable and inertial cavitation[1][2][4][6]. Microbubble resonance is a biophysical property rather than a biomolecular target and is not specific to a single protein, receptor, or enzyme.
Enhancement of ultrasound backscatter via nonlinear resonance Temporary increase in tissue permeability (by cavitation or oscillation) Induction of localized mechanical bioeffects (stable and inertial cavitation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ultrasound contrast agent microbubble.